>
bibliography
Initial Testing
Burke,
M.T., Gralla, R., Kris, M., Howard, J., & Monras, P. (1985).
Subjective evaluation in non-small cell lung cancer: Comparison
of Karnofsky performance status with a patient generated visual analogue
scale measuring activity. Proceedings of the IVth World Conference
on Lung Cancer, 4, 42.
Monras, P., Gralla, R.J., Burke, M.T., Kris, M.G., Howard, J., Niedzwiecki,
D., & Folman, R. (1985). Development of specific
instruments for subjective evaluation of patients with lung cancer:
Comparison of observer assessment with patient generated visual
analogue scales (VAS). Proceedings of the American
Society of Clinical Oncology, 4, 251.
Conceptual
Model
Hollen,
P.J., Gralla, R.J., Kris, M.G., & Cox, C. (1994).
Quality of life during clinical trials: Conceptual model for
the Lung Cancer Symptom Scale (LCSS). Supportive Care in Cancer,
2, 213-222.
Extended
Testing
Hollen,
P.J., Gralla, R.J., Kris, M.G., & Potanovich, L.M. (1993).
Quality of life assessment in individuals with lung cancer:
Testing the Lung Cancer Symptom Scale (LCSS). European
Journal of Cancer, 29A, S51-S58.
Hollen,
P.J., Gralla, R.J., Kris, M.G., Cox, C., Belani, C.P., Grunberg,
S.M., Crawford, J., & Neidhart, J.A. (1994). Measurement
of quality of life in patients with lung cancer in multicenter trials
of new therapies: Psychometric assessment of the Lung Cancer
Symptom Scale. Cancer, 73, 2087-2098.
Analysis
Methods
Hollen,
P.J., Gralla, R.J., Cox, C., & Eberly, S.W. (1994).
A dilemma in analysis: Measurement issues in the longitudinal
analysis of quality of life in 673 patients with advanced lung cancer.
Proceedings of the American Society of Clinical Oncology,
13, 329.
Hollen, P.J., Gralla, R.J., Cox, C., Eberly, S.W., & Kris, M.G.
(1997). A dilemma in analysis: Issues in the serial
measurement of quality of life in patients with advanced lung cancer.
Lung Cancer, 18, 119-136.
Hollen, P.J., Gralla, R.J., Rittenberg, C.N., Marques, C.B., &
Silverman, C.R. (1999). Quality of life as a clinical
trial endpoint: Developing a method to determine an appropriate
interval for serial assessment. 5th National Conference on
Cancer Nursing Research, Amercian Cancer Society, & Association
of Pediatric Oncology Nurses. Newport Beach, CA, February
11-13, 1999.
Gralla, R.J., Rittenberg, C.N., Hollen, P.J., Silverman, C.R., &
Marques, C.B. (1999). How frequently should quality
of life measures be repeated in patients receiving chemotherapy
for non-small cell lung cancer: Results of a prospective evaluation.
Proceedings of the 11th MASCC International Symposium. Nice,
France, February 18-20, 1999.
Hollen, P.J., Gralla, R.J., & Kris, M.G. (1995).
Lung Cancer Symptom Scale (LCSS): Administration, scoring,
and procedures manual -- Version 1.1 (Available from first
author).
Modifications
Hollen, P.J., Gralla R.J., Liepa A.M., Symanowski, J.T., & Rusthoven, J.J. (2006). Measuring quality of life in patients with pleural mesothelioma using a modified version of the Lung Cancer Symptom Scale (LCSS): Psychometric properties of the LCSS-Meso. Supportive Care in Cancer, 14, 11-21.
Hollen P.J., Gralla R.J., Liepa A.M., Symanowski, J.T., & Rusthoven, J.J. (2004). Adapting the Lung Cancer Symptom Scale (LCSS) to Mesothelioma: Using the LCSS-Meso conceptual model for validation. Cancer, 101(3), 587-597.
Gralla, R.J., Hollen, P.J., Liepa, A.M., Symanowski, J.T., Rusthoven, J.J., Boyer, M.J., Jassem, J., Vogelzang, N.J. (2003). Documenting symptom palliation with chemotherapy using the LCSS-Meso: Results from the randomized trial of pemetrexed plus cisplatin vs. cisplatin alone in patients with malignant pleural mesothelioma. European Journal of Cancer, Suppl 1, S272.
Gralla, R.J., Hollen, P.J., Liepa, A.M., Symanowski, J.T., Boyer, M.J., Jassem, J., Abraham, R., Rusthoven, J.R., & Vogelzang, N.J. (2003). Improving Quality of Life in Patients with Malignant Pleural Mesothelioma: Results of the Randomized Pemetrexed + Cisplatin vs Cisplatin Trial Using the LCSS-Meso Instrument. Proceedings of the American Society of Clinical Oncology, 22, 621 [abstr 2496].
Gralla, R.J., Symanowski, J.T., Liepa, A.M., Boyer, M.J., Ruffie, P., Moro-Sibilot, D., Hollen, P.J. & Rusthoven, J.J. (2003). Can baseline quality of life parameters predict survival and other efficacy outcomes in malignant pleural mesothelioma?: Results from a 448-patient phase III trial. Lung Cancer, 41, S220.
Gralla, R.J., Hollen, P.J., Liepa, A.M., & Rusthoven, J.J (2001). Health-related quality of life of patients with malignant pleural mesothelioma treated with pemetrexed disodium. Eur J Cancer 2001; 37(6):282 [abstr 312].
Additional
Hollen, P.J., Gralla, R.J. Kris, M.G., McCoy, S., & Moinpour, C.M. (2005). A comparison of visual analogue and numerical rating scale formats for the Lung Cancer Symptom Scale: Does format affect patient ratings of symptoms and quality of life? Quality of Life Research, 14, 837-848.
Hollen, P.J., Gralla, R.J., & Rittenberg, C.N. (2004). Quality of life as a clinical trial endpoint: Determining the appropriate interval for repeated assessments in patients with advanced lung cancer. Supportive Care in Cancer, 12, 767-773.
Hollen,
P.J., & Gralla, R.J. (1996). Comparison of instruments
for measuring quality of life in patients with lung cancer.
Seminars in Oncology, 23, (Suppl5), 31-40.
_________________________________
* derived by LCSS
|